These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26098302)
61. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection. Zhu D; Jiang S; Luo X Vaccine; 2005 Aug; 23(37):4619-24. PubMed ID: 16053938 [TBL] [Abstract][Full Text] [Related]
62. HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Taylor JL; Wieczorek A; Keyser AR; Grover A; Flinkstrom R; Karls RK; Bielefeldt-Ohmann H; Dobos KM; Izzo AA Immunol Cell Biol; 2012 Nov; 90(10):945-54. PubMed ID: 22801575 [TBL] [Abstract][Full Text] [Related]
63. Potentiation of Th1-Type Immune Responses to Ko A; Wui SR; Ryu JI; Lee YJ; Hien DTT; Rhee I; Shin SJ; Park SA; Kim KS; Cho YJ; Lee NG J Microbiol Biotechnol; 2018 Jan; 28(1):136-144. PubMed ID: 29081214 [TBL] [Abstract][Full Text] [Related]
64. A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice. Li G; Liu G; Song N; Kong C; Huang Q; Su H; Bi A; Luo L; Zhu L; Xu Y; Wang H Mol Immunol; 2015 Aug; 66(2):346-56. PubMed ID: 25942359 [TBL] [Abstract][Full Text] [Related]
65. Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A. Stylianou E; Griffiths KL; Poyntz HC; Harrington-Kandt R; Dicks MD; Stockdale L; Betts G; McShane H Vaccine; 2015 Nov; 33(48):6800-8. PubMed ID: 26478198 [TBL] [Abstract][Full Text] [Related]
66. [Prokaryotic expression and immunological characteristics of Mycobacterium tuberculosis Rv1886c]. Tao C; Zhao D; Dong H; Shan F; Lian K; Pan Z; Chen X; Yin Y; Jiao X Wei Sheng Wu Xue Bao; 2014 Mar; 54(3):330-7. PubMed ID: 24984525 [TBL] [Abstract][Full Text] [Related]
67. IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization. Luo Y; Ma X; Liu X; Lu X; Niu H; Yu H; Bai C; Peng J; Xian Q; Wang Y; Zhu B Int Immunol; 2016 Feb; 28(2):77-85. PubMed ID: 26521300 [TBL] [Abstract][Full Text] [Related]
68. Production and Evaluation of Ag85B:HspX:hFcγ1 Immunogenicity as an Fc Fusion Recombinant Multi-Stage Vaccine Candidate Against Mycobacterium tuberculosis. Karbalaei M; Mosavat A; Soleimanpour S; Farsiani H; Ghazvini K; Amini AA; Sankian M; Rezaee SA Curr Microbiol; 2024 Apr; 81(5):127. PubMed ID: 38575759 [TBL] [Abstract][Full Text] [Related]
69. New multistage TB vaccine shown to produce stronger, longer-lasting response against Mycobacterium tuberculosis. Immunotherapy; 2011 Mar; 3(3):309. PubMed ID: 21395372 [No Abstract] [Full Text] [Related]
70. Human type 5 adenovirus-based tuberculosis vaccine: is the respiratory route of delivery the future? Smaill F; Xing Z Expert Rev Vaccines; 2014 Aug; 13(8):927-30. PubMed ID: 24935214 [TBL] [Abstract][Full Text] [Related]
71. Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Weinrich Olsen A; van Pinxteren LA; Meng Okkels L; Birk Rasmussen P; Andersen P Infect Immun; 2001 May; 69(5):2773-8. PubMed ID: 11292688 [TBL] [Abstract][Full Text] [Related]
72. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice. Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431 [TBL] [Abstract][Full Text] [Related]
73. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines. Tyne AS; Chan JG; Shanahan ER; Atmosukarto I; Chan HK; Britton WJ; West NP Vaccine; 2013 Sep; 31(40):4322-9. PubMed ID: 23880366 [TBL] [Abstract][Full Text] [Related]
74. Subunit Vaccines Consisting of Antigens from Dormant and Replicating Bacteria Show Promising Therapeutic Effect against Mycobacterium Bovis BCG Latent Infection. Li F; Kang H; Li J; Zhang D; Zhang Y; Dannenberg AM; Liu X; Niu H; Ma L; Tang R; Han X; Gan C; Ma X; Tan J; Zhu B Scand J Immunol; 2017 Jun; 85(6):425-432. PubMed ID: 28426145 [TBL] [Abstract][Full Text] [Related]
75. Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis. Shi S; Yu L; Sun D; Liu J; Hickey AJ Pharm Res; 2010 Feb; 27(2):224-34. PubMed ID: 19862606 [TBL] [Abstract][Full Text] [Related]
76. A lentiviral vector-based therapeutic vaccine encoding Ag85B-Rv3425 potently increases resistance to acute tuberculosis infection in mice. Yang E; Wang F; Xu Y; Wang H; Hu Y; Shen H; Chen ZW Acta Biochim Biophys Sin (Shanghai); 2015 Aug; 47(8):588-96. PubMed ID: 26112017 [TBL] [Abstract][Full Text] [Related]
77. A subunit vaccine based on biodegradable microspheres carrying rHsp65 protein and KLK protects BALB/c mice against tuberculosis infection. dos Santos SA; Zárate-Bladés CR; de Sá Galetti FC; Brandão IT; Masson AP; Soares EG; Araújo AP; Silva CL Hum Vaccin; 2010 Dec; 6(12):1047-53. PubMed ID: 21157178 [TBL] [Abstract][Full Text] [Related]
78. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Brandt L; Elhay M; Rosenkrands I; Lindblad EB; Andersen P Infect Immun; 2000 Feb; 68(2):791-5. PubMed ID: 10639447 [TBL] [Abstract][Full Text] [Related]
79. Construction and evaluation of a novel multi-antigenic Mycobacterium tuberculosis subunit vaccine candidate BfrB-GrpE/DPC. Niu H; Cao Q; Zhang T; Du Y; He P; Jiao L; Wang B; Zhu B; Hu L; Zhang Y Int Immunopharmacol; 2023 Nov; 124(Pt B):111060. PubMed ID: 37862738 [TBL] [Abstract][Full Text] [Related]
80. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Aagaard C; Hoang T; Dietrich J; Cardona PJ; Izzo A; Dolganov G; Schoolnik GK; Cassidy JP; Billeskov R; Andersen P Nat Med; 2011 Feb; 17(2):189-94. PubMed ID: 21258338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]